Vascular malformations may benefit from targeting the dysregulated PI3K/AKT/mTOR pathway through PTEN restoration or mimetic compounds, potentially helping to modulate aberrant cellular growth and improve patient outcomes. Here, MTOR is linked to vascular malformation.